Pressure and the diabetic foot: clinical science and offloading techniques

被引:83
作者
Boulton, AJM
机构
[1] Univ Miami, Dept Med, Div Endocrinol, Miami, FL 33101 USA
[2] Univ Manchester, Manchester Royal Infirm, Dept Med, Manchester M13 9WL, Lancs, England
关键词
D O I
10.1016/S0002-9610(03)00297-6
中图分类号
R61 [外科手术学];
学科分类号
摘要
Diabetic foot ulceration is a common, yet in many cases an eminently preventable, complication that affects 1 in 20 patients with diabetes. Risk factors for ulceration include insensitivity (secondary to somatic neuropathy), high foot pressures, callus formation (a consequence of sympathetic neuropathy and high foot pressures), deformities (such as claw feet, prominent metatarsal heads, etc.), peripheral vascular disease, and most importantly, a past history of ulceration. None of these factors alone causes ulceration; thus, early identification and amelioration of these factors is a primary aim in foot ulcer prevention. A number of therapeutic approaches may help reduce ulcer incidence: these include therapeutic footwear, hosiery, and, potentially, liquid silicone injected under high-pressure areas. In the management of neuropathic ulcers, pressure relief is of the utmost importance, and total contact casting remains the "gold standard" means of achieving such pressure redistribution. The successful management of diabetic foot ulceration depends on a team approach, remembering that ulcers should heal if (1) the arterial circulation is intact, (2) pressure relief is achieved and maintained over the ulcer, and (3) infection is appropriately treated. (C) 2004 Excerpta Medica, Inc. All rights reserved.
引用
收藏
页码:17S / 24S
页数:8
相关论文
共 39 条
[1]
The North-West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort [J].
Abbott, CA ;
Carrington, AL ;
Ashe, H ;
Bath, S ;
Every, LC ;
Griffiths, J ;
Hann, AW ;
Hussein, A ;
Jackson, N ;
Johnson, KE ;
Ryder, CH ;
Torkington, R ;
Van Ross, ERE ;
Whalley, AM ;
Widdows, P ;
Williamson, S ;
Boulton, AJM .
DIABETIC MEDICINE, 2002, 19 (05) :377-384
[2]
Multicenter study of the incidence of and predictive risk factors for diabetic neuropathic foot ulceration [J].
Abbott, CA ;
Vileikyte, L ;
Williamson, S ;
Carrington, AL ;
Boulton, AJM .
DIABETES CARE, 1998, 21 (07) :1071-1075
[3]
Plantar tissue thickness is related to peak plantar pressure in the high-risk diabetic foot [J].
Abouaesha, F ;
van Schie, CHM ;
Griffths, GD ;
Young, RJ ;
Boulton, AJM .
DIABETES CARE, 2001, 24 (07) :1270-1274
[4]
[Anonymous], 2000, FOOT DIABETES
[5]
[Anonymous], 1995, FOOT
[6]
Armstrong D G, 1998, Clin Podiatr Med Surg, V15, P95
[7]
Continuous activity monitoring in persons at high risk for diabetes-related lower-extremity amputation [J].
Armstrong, DG ;
Abu-Rumman, PL ;
Nixon, BP ;
Boulton, AJM .
JOURNAL OF THE AMERICAN PODIATRIC MEDICAL ASSOCIATION, 2001, 91 (09) :451-455
[8]
Activity monitors: Should we begin dosing activity as we dose a drug? [J].
Armstrong, DG ;
Boulton, AJM .
JOURNAL OF THE AMERICAN PODIATRIC MEDICAL ASSOCIATION, 2001, 91 (03) :152-153
[9]
Off-loading the diabetic foot wound - A randomized clinical trial [J].
Armstrong, DG ;
van Schie, CHM ;
Nguyen, HC ;
Boulton, AJM ;
Lavery, LA ;
Harkless, LB .
DIABETES CARE, 2001, 24 (06) :1019-1022
[10]
BALKIN S, 1992, FOOT, V2, P83